Latest News & Events

Procarta attends the Microbiome Invest Conference 2019

The Procarta management team, comprised of Andrew Lightfoot, Nikki D'Arcy and Martin…

Read more

"No Time to Wait: Securing the future from drug-resistant infections"

Infectious Diseases Hub article on the latest report from the UN Interagency…

Read more

Procarta presents our Transcription Factor Decoy technology at ECCMID 2019

Procarta Co-founder Professor Michael McArthur presented our exciting Transcription Factor Decoy (TFD)…

Read more

Procarta presents at the Microbiology Society Annual Conference 2019

The Procarta research team, lead by Procarta Co-founder Professor Michael McArthur, attended…

Read more

Procarta CEO attends the Berlin CMR Conference 2019

Procarta Biosystems Ltd. attended the Berlin Novel Antimicrobials and AMR Diagnostics Conference…

Read more

PROCARTA ANNOUNCES €1.5 MILLION INVESTMENT FOR NEW CLASS OF ANTIBIOTICS TO COMBAT ANTIMICROBIAL RESISTANCE

Press Release - Stevenage, UK, 5th March, 2019 – Procarta Biosystems, a…

Read more

"Antibiotic resistance plan to fight 'urgent' global threat"

BBC News report on British Government plans to combat antimicrobial resistance.

https://www.bbc.co.uk/news/health-46973641

Read more

Procarta at BioSeed Life Science Investment Event

CEO of Procarta Biosystems Ltd. Dr. Andrew Lightfoot attended the BioSeed Early…

Read more

Procarta Biosystems Ltd speak at BioInfect 2018

Procarta's Chief Scientific Officer, Professor Michael McArthur, was invited to speak at…

Read more

NOW HIRING - Post-doctoral and Research Technician positions  

Two positions are available to join a laboratory developing novel oligonucleotide antimicrobials,…

Read more